+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Medical Aesthetics Market (2021-2026) by Product, Treatment, Operation, End-user & Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 177 Pages
  • November 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5515377
The Global Medical Aesthetics Market is estimated to be USD 15.15 Bn in 2021 and is expected to reach USD 28.04 Bn by 2026, growing at a CAGR of 13.10%.



Market Dynamics

In the past two decades, medical aesthetic procedures have become increasingly popular. The market has witnessed significant growth in the demand for aesthetic treatments due to the rise in the number of doctors and surgeons providing safe and effective medical aesthetic treatments and the launch of technologically advanced products. Growing adoption of cosmetic procedures among the population, availability of technologically advanced & user-friendly products, and increasing public awareness about cosmetic procedures are some of the major factors driving the market's growth.

However, medical aesthetic procedures are associated with various possible side effects. Patients undergoing aesthetic treatments may face several risks and complications after or during the procedure. Hence, clinical risks and complications associated with medical aesthetic procedures and the availability of alternative and cosmetic products are the restraining factors for the market growth.

Market Segmentation

The Global Medical Aesthetics Market is segmented further based on Product, Treatment, Operation, End-user & Geography.

By Product, the market is classified into Facial Aesthetic Products, Body Contouring Devices, Cosmetic Implants, Hair Removal Devices, Skin Aesthetic Devices, Tattoo Removal Devices, Thread Lift Products, Physician-Dispensed Cosmeceuticals, and Skin Lighteners, Physician-Dispensed Eyelash Products and Nail Treatment Laser Devices.

By Treatment, the market is classified into Anti-Aging & Wrinkles, Body Shaping & Cellulite, Breast Enhancement, Facial & Skin Rejuvenation, Pigment, Lesions, Psoriasis, Reconstructive, Sears, Tattoo Removal, Vascular Lesions, and Vitiligo.

By Operation, the market is classified into Non-Surgical and Surgical Procedures.

By End User, the market is classified into Clinics, Hospitals, Medical Spas, Beauty Centres, and Home Care.

By Geography, North America is expected to lead the market.

Recent Developments

1. Cynosure, the global leader in medical aesthetics, announced today the U.S. and Canadian launch of its ViaSure™ device to effectively treat the underlying causes, and not just the symptoms, of vascular-related sexual performance issues in men.. - 1st Nov 2021
2. Establishment Labs Holdings Inc., a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced the launch of JOY™, a new patient-centric breast aesthetics program.. - 14th Oct 2021
3. Bausch Health plans IPO for medical aesthetics business to cut debt.. - 4th August 2021

Company Profiles

Some of the companies covered in this report are Allergan PLC, Alma Lasers, Ltd., Anika Therapeutics Inc., Cutera, Inc., Cynosure LLC, Fotona d.o.o., Galderma S.A., Johnson & Johnson, Medytox, Inc., Sientra, Inc., Sinclair Pharma PLC, Baush Haealth, Candela Corporation, Bosch Healthcare Solutions GmbH, Establishment Labs Holdings Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Insulated Packaging Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Medical Aesthetics Market

What is the estimated value of the Global Medical Aesthetics Market?

The Global Medical Aesthetics Market was estimated to be valued at $15150 Million in 2021.

What is the growth rate of the Global Medical Aesthetics Market?

The growth rate of the Global Medical Aesthetics Market is 13.1%, with an estimated value of $28040 Million by 2026.

What is the forecasted size of the Global Medical Aesthetics Market?

The Global Medical Aesthetics Market is estimated to be worth $28040 Million by 2026.

Who are the key companies in the Global Medical Aesthetics Market?

Key companies in the Global Medical Aesthetics Market include Allergan PLC, Alma Lasers, Ltd., Anika Therapeutics Inc., Cutera, Inc., Cynosure LLC, El.En. S.P.A., Fotona d.o.o., Galderma S.A. and Merz Pharma GmbH & Co. KGaA.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Growing Adoption of Cosmetic Procedures Among the Population
4.1.2 Rising Incidences of Skin Diseases
4.1.3 Availability of Technologically Advanced & User-Friendly Products
4.1.4 Increasing Public Awareness About Cosmetic Procedures
4.2 Restraints
4.2.1 Availability of Alternative and Cosmetic Products
4.2.2 Clinical Risks and Complications Associated with Medical Aesthetic Procedures
4.3 Opportunities
4.3.1 Rapid Growth in Medical Tourism
4.3.2 Increasing Disposable Income Among Population
4.4 Challenges
4.4.1 Social and Cultural Barriers in Certain Emerging Economies
4.4.2 High Cost Associated with the Treatment and Lack of Reimbursement Policies
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Medical Aesthetics Market, By Product
6.1 Introduction
6.2 Facial Aesthetic Products
6.2.1 Dermal Fillers
6.2.2 Botulinum Toxin
6.2.3 Microdermabrasion
6.2.4 Chemical Peels
6.3 Body Contouring Devices
6.3.1 Nonsurgical Fat Reduction Devices
6.3.2 Cellulite Reduction Devices
6.3.3 Liposuction Devices
6.4 Cosmetic Plants
6.4.1 Breast Silicone Implants
6.4.2 Breast Saline Implants
6.4.3 Facial Implants
6.4.4 Gluteal Implants
6.5 Hair Removal Devices
6.5.1 Laser Hair Removal Devices
6.5.2 IPL Hair Removal Devices
6.6 Skin Aesthetic Devices
6.6.1 Laser Resurfacing Devices
6.6.2 Non-Surgical Tightening Devices
6.6.3 Micro-needling Devices
6.6.4 Light Therapy Devices
6.7 Tattoo Removal Devices
6.8 Thread Lift Products
6.9 Physician-dispensed Cosmeceuticals and Skin Lighteners
6.10 Physician-dispensed Eyelash Products
6.11 Nail Treatment Laser Devices
7 Global Medical Aesthetics Market, By Treatment
7.1 Anti-Ageing and wrinkles
7.2 Body Shaping and Cellulite
7.3 Breast enhancement
7.4 Facial & Skin rejuvenation
7.5 Pigment
7.6 Lesions
7.7 Psoriasis
7.8 Reconstructive
7.9 Sears
7.10 Tattoo Removal
7.11 Vascular Lesions
7.12 Vitiligo
8 Global Medical Aesthetics Market, By Operation
8.1 Introduction
8.2 Surgical Procedure
8.3 Non-Surgical Procedure
9 Global Medical Aesthetics Market, By End User
9.1 Introduction
9.2 Clinics, Hospitals, and Medical Spas
9.3 Beauty Centres
9.4 Home Care
10 Global Medical Aesthetics Market, By Geography
10.1 Introduction
10.2 America
10.2.1 Argentina
10.2.2 Brazil
10.2.3 Canada
10.2.4 Chile
10.2.5 Colombia
10.2.6 Mexico
10.2.7 Peru
10.2.8 United States
10.2.9 Rest of Americas
10.3 Europe
10.3.1 Austria
10.3.2 Belgium
10.3.3 Denmark
10.3.4 Finland
10.3.5 France
10.3.6 Germany
10.3.7 Italy
10.3.8 Netherlands
10.3.9 Norway
10.3.10 Poland
10.3.11 Russia
10.3.12 Spain
10.3.13 Sweden
10.3.14 Switzerland
10.3.15 United Kingdom
10.3.16 Rest of Europe
10.4 Middle East and Africa
10.4.1 Egypt
10.4.2 Israel
10.4.3 Qatar
10.4.4 Saudi Arabia
10.4.5 South Africa
10.4.6 United Arab Emirates
10.4.7 Rest of MEA
10.5 Asia-Pacific
10.5.1 Australia
10.5.2 Bangladesh
10.5.3 China
10.5.4 India
10.5.5 Indonesia
10.5.6 Japan
10.5.7 Malaysia
10.5.8 Philippines
10.5.9 Singapore
10.5.10 South Korea
10.5.11 Sri Lanka
10.5.12 Thailand
10.5.13 Taiwan
10.5.14 Rest of Asia-Pacific
11 Competitive Landscape
11.1 Competitive Quadrant
11.2 Market Share Analysis
11.3 Strategic Initiatives
11.3.1 M&A and Investments
11.3.2 Partnerships and Collaborations
11.3.3 Product Developments and Improvements
12 Company Profiles
12.1 Allergan PLC
12.2 Alma Lasers, Ltd.
12.3 Anika Therapeutics Inc.
12.4 Cutera, Inc.
12.5 Cynosure LLC
12.6 El.En. S.P.A.
12.7 Fotona d.o.o.
12.8 Galderma S.A.
12.9 Johnson & Johnson
12.10 Merz Pharma GmbH & Co. KGaA
12.11 Medytox, Inc.
12.12 Sientra, Inc.
12.13 Sinclair Pharma PLC
12.14 Syneron Medical, Ltd.
12.15 Baush Haealth
12.16 Candela Corporation
12.17 Groupe Sebbin SAS
12.18 Bosch Healthcare Solutions GmbH
12.19 Establishment Labs Holdings Inc.
12.20 Nobel Biocare Services AG
13 Appendix
13.1 Questionnaire

Companies Mentioned

  • Allergan PLC
  • Alma Lasers, Ltd.
  • Anika Therapeutics Inc.
  • Cutera, Inc.
  • Cynosure LLC
  • El.En. S.P.A.
  • Fotona d.o.o.
  • Galderma S.A.
  • Johnson & Johnson
  • Merz Pharma GmbH & Co. KGaA
  • Medytox, Inc.
  • Sientra, Inc.
  • Sinclair Pharma PLC
  • Syneron Medical, Ltd.
  • Baush Haealth
  • Candela Corporation
  • Groupe Sebbin SAS
  • Bosch Healthcare Solutions GmbH
  • Establishment Labs Holdings Inc.
  • Nobel Biocare Services AG